metformin has been researched along with humulin s in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 14 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Nixon, A | 1 |
| Amin, N; Baughman, R; Franco, D; Korpachev, V; Ma, Y; McGill, JB; Rosenstock, J; Shumel, B | 1 |
| Emery, A; Gerstein, HC; Harris, SB; Kramer, CK; McInnes, N; Reichert, SM; Retnakaran, R; Thorpe, KE; Ye, C; Zinman, B | 1 |
| Bateman, BT; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Patorno, E; Seely, EW; Vine, S; Wood, ME | 1 |
| Balungi, PA; Carr, ALJ; Hattersley, AT; Jones, AG; Mwebaze, R; Niwaha, AJ; Nyirenda, MJ; Rodgers, LR; Shields, BM | 1 |
| Cui, N; Feng, W; Guo, L; Jiang, C; Li, Y; Liang, L; Liu, J; Mu, Y; Pan, Q; Wan, H; Wang, G; Wang, J; Wang, T; Xu, B; Zhang, X | 1 |
| Alyakin, A; Clark, C; Hart, B; Powell, M; Vogelstein, JT | 1 |
| Boutmy, E; Brand, KM; Foch, C; Hakkarainen, KM; Saarelainen, L; Schlachter, J; Sõnajalg, J; Thoren, R | 1 |
| Baviera, M; Carla Roncaglioni, M; Foresta, A; Fortino, I; Macaluso, G; Nobili, A; Ojeda-Fernández, L; Sesti, G; Succurro, E | 1 |
| Alwakeel, M; Bena, J; Buehler, L; Lansang, MC; Makin, V; Obiri-Yeboah, D; Pantalone, KM; Zhou, K | 1 |
| Koskensalo, K; Loo, BM; Niinikoski, H; Nikkinen, H; Paavilainen, E; Parkkola, R; Rönnemaa, T; Tertti, K; Tossavainen, P; Vääräsmäki, M; Veijola, R | 1 |
| Cesta, CE; Cohen, JM; Engeland, A; Furu, K; Gissler, M; Gulseth, HL; Karlstad, Ø; Kjerpeseth, LJ; Leinonen, MK; Pazzagli, L; Zoega, H | 1 |
| Banu, I; Biondi-Zoccai, G; Charnaux, N; Cosson, E; Fysekidis, M; Sabouret, P; Sutton, A; Takbou, K; Testa, A; Valensi, P; Vicaut, E | 1 |
| Abd El Aziz, M; Nauck, MA; Wollenhaupt, D; Wolters, J | 1 |
| Levita, J; Sumiwi, SA; Susilawati, E; Susilawati, Y | 1 |
| Aydin, B; Bergsten, P; Chowdhury, AI; Forslund, A; Shekha, M; Stenlid, R; Wen, Q | 1 |
2 review(s) available for metformin and humulin s
| Article | Year |
|---|---|
Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis.
Topics: Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Metformin; Sulfonylurea Compounds | 2023 |
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2023 |
5 trial(s) available for metformin and humulin s
| Article | Year |
|---|---|
Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.
Topics: Administration, Inhalation; Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin, Regular, Human; Male; Metformin; Microspheres; Middle Aged; Placebos; Powders; Treatment Outcome | 2015 |
Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trial.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Regular, Human; Metformin | 2021 |
Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, rando
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Regular, Human; Metformin | 2022 |
Metformin versus insulin for gestational diabetes: Adiposity variables and adipocytokines in offspring at age of 9 years.
Topics: Adipokines; Adiponectin; Adiposity; Child; Diabetes, Gestational; Female; Humans; Inflammation; Insulin; Insulin, Regular, Human; Leptin; Male; Metformin; Obesity; Pregnancy | 2023 |
Insulin analogs as an add-on to metformin after failure to oral treatment in type 2 diabetic patients increase diastole duration. The INSUlin Regimens and VASCular Functions (INSUVASC) study.
Topics: Adult; Diabetes Mellitus, Type 2; Diastole; Female; Humans; Insulin; Insulin, Regular, Human; Male; Metformin; Middle Aged; Pulse Wave Analysis | 2023 |
9 other study(ies) available for metformin and humulin s
| Article | Year |
|---|---|
Switching a hyperinsulinemic patient from insulin to oral hypoglycemics.
Topics: Developmental Disabilities; Diabetes Mellitus; Diet; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Insulin, Regular, Human; Male; Metformin; Middle Aged | 2012 |
The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States.
Topics: Diabetes Mellitus, Type 2; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Male; Metformin; Pregnancy; Sulfonylurea Compounds; United States | 2022 |
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemia; Insulin; Insulin, Regular, Human; Metformin; Sulfonylurea Compounds | 2022 |
Exploration of Residual Confounding in Analyses of Associations of Metformin Use and Outcomes in Adults With Type 2 Diabetes.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Insulin, Regular, Human; Male; Medicare Part C; Metformin; Retrospective Studies; United States | 2022 |
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study.
Topics: Child; Cohort Studies; Diabetes, Gestational; Female; Follow-Up Studies; Humans; Infant, Newborn; Insulin; Insulin, Regular, Human; Metformin; Pregnancy; Weight Gain | 2022 |
Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds | 2023 |
Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019-Related Hospital Outcomes in Patients with Type 2 Diabetes.
Topics: COVID-19; Diabetes Mellitus, Type 2; Dipeptidases; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Hospitals; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Metformin; Renal Insufficiency; Retrospective Studies | 2023 |
Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study.
Topics: Abnormalities, Drug-Induced; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Insulin, Regular, Human; Metformin; Pregnancy | 2023 |
Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate-exposed human islets.
Topics: Adolescent; Carboxypeptidase H; Diabetes Mellitus, Type 2; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin, Regular, Human; Islets of Langerhans; Metformin; Palmitates; Pediatric Obesity; Prediabetic State; Proinsulin | 2023 |